Beta Glucan Based Products Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Beta Glucan Based Products Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Beta glucan is an important component of dietary fiber, which can be extracted from oat, barley, bacteria, and yeast. It possesses several physiological effects, including lowering plasma cholesterol level, control of postprandial glucose level, and immune modulation effects. Apart from the food industry, beta glucan is increasingly being used in the pharmaceutical, medical, cosmetic, and industrial applications, and end product manufacturing.
Βeta glucans can act as an immune system modulator and also has the ability to reduce blood glucose, and it may be used in the treatment of diabetes mellitus. Beta glucans can protect the body from heart attack by lowering cholesterol levels and it also acts as an anti-tumor agent. Beta glucans are used in medical field to treat various diseases including hyper cholesterolemia, diabetes, cancer, and HIV/AIDS.
Market Dynamics
Increasing applications of beta glucan as potential active ingredient in various food, medical, pharmaceutical, animal feed, and industrial applications is expected to increase demand for beta glucan and this is expected to aid in growth of the market in the near future. Moreover, health benefits of beta glucan along with changing consumer preferences towards use of nutritious food and dietary supplements among global population is expected to propel the market growth.
Furthermore, key players in the market are focusing on gaining significant market share by adopting various strategies and this is expected to aid in the market growth. For instance, in April 2017, Kemin Industries acquired a beta-glucan manufacturing technology from Algal Scientific, a company headquartered in Plymouth, U.S. In October 2014, NutraQ announced that it entered into a distribution partnership with American International Chemical LLC (AIC) to exclusively distribute NBG range of beta-glucans in in the U.S., Canada, and Mexico.
Key features of the study:
This report provides in-depth analysis of beta glucan based products market and provides market size (US$ Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
This study also provides key insights into market drivers, restraints, opportunities, scoliosis management product approval & launch, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global beta glucan based products market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as part of this study include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc., and AIPPO
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, manufacturing up-gradation, market expansion, and marketing tactics
The global beta glucan based products market report caters to various stakeholders in this industry including investors, suppliers, beta glucan based product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the beta glucan based products market
Detailed Segmentation:
Global Beta Glucan Based Products Market, By Source:
Cereals
Yeast
Mushroom
Others
Global Beta Glucan Based Products Market, By Grade:
Pharma
Medical
Food
Cosmetics
Enhanced Oil Recovery (EOR)
Animal Feed
Global Beta Glucan Based Products Market, By Region:
North America
By Country:
U.S.
Canada
By Source:
Cereals
Yeast
Mushroom
Others
By Grade
Pharma
Medical
Food
Cosmetics
Enhanced Oil Recovery (EOR)
Animal Feed
Europe
By Country:
Germany
France
Italy
U.K.
Spain
Russia
Rest of Europe
By Source:
Cereals
Yeast
Mushroom
Others
By Grade
Pharma
Medical
Food
Cosmetics
Enhanced Oil Recovery (EOR)
Animal Feed
Asia Pacific
By Country:
China
India
Japan
South Korea
Australia
Rest of Asia Pacific
By Source:
Cereals
Yeast
Mushroom
Others
By Grade
Pharma
Medical
Food
Cosmetics
Enhanced Oil Recovery (EOR)
Animal Feed
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Source:
Cereals
Yeast
Mushroom
Others
By Grade
Pharma
Medical
Food
Cosmetics
Enhanced Oil Recovery (EOR)
Animal Feed
Latin America
By Country:
Brazil
Argentina
Mexico
Rest of Latin America
By Source:
Cereals
Yeast
Mushroom
Others
By Grade
Pharma
Medical
Food
Cosmetics
Enhanced Oil Recovery (EOR)
Animal Feed
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Source:
Cereals
Yeast
Mushroom
Others
By Grade
Pharma
Medical
Food
Cosmetics
Enhanced Oil Recovery (EOR)
Animal Feed
Company Profiles
Merck KGaA*
Company Overview
Product Portfolio
Financial Performance
Recent Developments
Strategies
Jkosmmune
Lesaffre Group
Garuda International, Inc.
Ohly GmBH
Koninklijke DSM N.V.
Kerry Group PLC
STR Biotech Co. Ltd.
Macrocare Tech Co., Ltd.
Amarte USA, LLC
Ceapro Inc.
Biotec Pharmacon ASA
Quegen Biotech Co., Ltd.
Kemin Industries, Inc.
NutraQ AS
Lantmännen
Carbon Medical Technologies, Inc.
Givaudan SA
Danaher Corporation
Super Beta Glucan Inc.
AIPPO
“*” marked represents similar segmentation in other categories in the respective section.